Search Page

1

Cite

Share

Hypoxia-induced lncRNA CASC9 enhances glycolysis and the epithelial-mesenchymal transition of pancreatic cancer by a positive feedback loop with AKT/HIF-1α signaling [Retraction].

[No authors listed] [No authors listed] Am J Cancer Res. 2021 Jun 15;11(6):3377. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249470 Free PMC article.

Cite

Share

2

Cite

Share

MicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1 [Retraction].

[No authors listed] [No authors listed] Am J Cancer Res. 2021 Jun 15;11(6):3376. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249469 Free PMC article.

Cite

Share

3

Cite

Share

MicroRNA-613 suppresses proliferation, migration and invasion of osteosarcoma by targeting c-MET [Retraction].

[No authors listed] [No authors listed] Am J Cancer Res. 2021 Jun 15;11(6):3375. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249468 Free PMC article.

Cite

Share

4

Cite

Share

DLX5 promotes osteosarcoma progression via activation of the NOTCH signaling pathway.

Zhang X, Bian H, Wei W, Wang Q, Chen J, Hei R, Chen C, Wu X, Yuan H, Gu J, Lu Y, Cai C, Zheng Q. Zhang X, et al. Am J Cancer Res. 2021 Jun 15;11(6):3354-3374. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249467 Free PMC article.

Cite

Share

5

Cite

Share

SERMs suppresses the growth of ERα positive cervical cancer xenografts through predominant inhibition of extra-nuclear ERα expression.

Ramachandran B, Murhekar K, Sundersingh S. Ramachandran B, et al. Am J Cancer Res. 2021 Jun 15;11(6):3335-3353. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249466 Free PMC article.

Cite

Share

6

Cite

Share

Low expression of miR-195 is associated with cell proliferation, glycolysis and poor survival in estrogen receptor (ER)-positive but not in triple negative breast cancer.

Tokumaru Y, Oshi M, Patel A, Katsuta E, Yan L, Angarita FA, Dasgupta S, Nagahashi M, Matsuhashi N, Futamura M, Yoshida K, Takabe K. Tokumaru Y, et al. Am J Cancer Res. 2021 Jun 15;11(6):3320-3334. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249465 Free PMC article.

Cite

Share

7

Cite

Share

Irreversible electroporation enhances immunotherapeutic effect in the off-target tumor in a murine model of orthotopic HCC.

Shi X, O'Neill C, Wang X, Chen Y, Yu Y, Tan M, Lv G, Li Y, Martin RC. Shi X, et al. Am J Cancer Res. 2021 Jun 15;11(6):3304-3319. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249464 Free PMC article.

Cite

Share

8

Cite

Share

Frailty is associated with mortality in brain tumor patients.

Torres-Perez P, Álvarez-Satta M, Arrazola M, Egaña L, Moreno-Valladares M, Villanua J, Ruiz I, Sampron N, Matheu A. Torres-Perez P, et al. Am J Cancer Res. 2021 Jun 15;11(6):3294-3303. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249463 Free PMC article.

Cite

Share

9

Cite

Share

A phase 1, multicenter study evaluating the safety and efficacy of KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma.

Cornell RF, Bishop MR, Kumar S, Giralt SA, Nooka AK, Larson SM, Locke FL, Raje NS, Lei L, Dong J, Le Gall JB, Rossi JM, Orlowski RZ. Cornell RF, et al. Am J Cancer Res. 2021 Jun 15;11(6):3285-3293. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249462 Free PMC article.

Cite

Share

10

Cite

Share

Inhibition of P53-mediated cell cycle control as the determinant in dedifferentiated liposarcomas development.

Stocker M, Le Nail LR, De Belenet H, Wunder JS, Andrulis IL, Gokgoz N, Levy N, Mattei JC, Olschwang S. Stocker M, et al. Am J Cancer Res. 2021 Jun 15;11(6):3271-3284. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249461 Free PMC article.

Cite

Share